- Home
- KROS vs VINP Comparison
KROS vs VINP Comparison
Compare KROS & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- VINP
- Stock Information
- Founded
- KROS 2015
- VINP 2009
- Country
- KROS United States
- VINP Brazil
- Employees
- KROS N/A
- VINP N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- VINP Investment Managers
- Sector
- KROS Health Care
- VINP Finance
- Exchange
- KROS Nasdaq
- VINP Nasdaq
- Market Cap
- KROS 558.9M
- VINP 593.2M
- IPO Year
- KROS 2020
- VINP 2021
- Fundamental
- Price
- KROS $14.53
- VINP $9.49
- Analyst Decision
- KROS Buy
- VINP Strong Buy
- Analyst Count
- KROS 13
- VINP 2
- Target Price
- KROS $20.63
- VINP $13.25
- AVG Volume (30 Days)
- KROS 477.3K
- VINP 58.3K
- Earning Date
- KROS 08-06-2025
- VINP 08-06-2025
- Dividend Yield
- KROS N/A
- VINP 6.87%
- EPS Growth
- KROS N/A
- VINP N/A
- EPS
- KROS 0.11
- VINP 0.38
- Revenue
- KROS $214,713,000.00
- VINP $126,696,258.00
- Revenue This Year
- KROS $5,006.76
- VINP $70.28
- Revenue Next Year
- KROS N/A
- VINP $14.37
- P/E Ratio
- KROS $132.80
- VINP $24.85
- Revenue Growth
- KROS 91657.70
- VINP 57.51
- 52 Week Low
- KROS $9.12
- VINP $8.66
- 52 Week High
- KROS $72.37
- VINP $11.62
- Technical
- Relative Strength Index (RSI)
- KROS 64.67
- VINP 45.90
- Support Level
- KROS $13.26
- VINP $9.20
- Resistance Level
- KROS $14.68
- VINP $9.94
- Average True Range (ATR)
- KROS 0.41
- VINP 0.22
- MACD
- KROS 0.12
- VINP -0.01
- Stochastic Oscillator
- KROS 89.35
- VINP 39.46
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.